Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis - Aims 2 and 3
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 110
- 试验地点
- 2
- 主要终点
- Intention for NMS treatment
研究概览
简要总结
The goal of this pilot hybrid type I efficacy/implementation trial is to assess a newly developed decision support tool patients, parents, and providers to use during surgical treatment decision making for neuromuscular scoliosis (NMS). Results from this pilot will inform the design of a future larger effectiveness trial of the decision support tool.
Participants will either receive usual care or receive the decision support tool. Researchers will assess the decision made, decision quality, individual affective, cognitive, and behavioral effects, and feasibility and acceptability of tool use. They will also collect potential barriers and facilitators to implementation and feedback about the tool and study design to maximize likelihood of successful deployment of the tool into clinical practice and inform the design of a future trial. The outcomes measures will be used to inform potential effect size estimates to inform a future trial.
详细描述
Neuromuscular scoliosis (NMS) can result in severe disability for children. Non-operative management including bracing and physical therapy minimally slows scoliosis progression, but operative management with posterior spinal fusion (PSF) carries high risks of morbidity and mortality in part due to the multiple comorbid conditions seen in children with NMS. Decisions like PSF that have no clear best treatment option are best served by shared decision making (SDM). SDM is a collaborative process where patients, parents, and providers share their knowledge, preferences, and values to reach treatment plan agreement. Our prior qualitative study creating a framework of SDM for children with multiple comorbid conditions like children with NMS found that parents face immense decision related uncertainty that often goes unacknowledged by providers and that parents and providers struggle with identifying and communicating family preferences and values that are important for treatment decision making. Our prior work has identified optimal methods to communicate uncertainty and identified the preferences and values parents of children with NMS have when it comes to treatment decision making for NMS. This study will pilot test a decision support tool that contains these elements.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Crossover
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 8 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Parent-child dyads of children with neuromuscular scoliosis who speak English and Spanish.
- •Child is between ages 8-21 years of age and they are coming into the pediatric orthopaedic surgery clinic for consultation about potential surgery for NMS.
- •NMS is defined as having neurologic impairment (NI) and scoliosis using relevant ICD-9 or ICD-10 codes from Feudtner, et al. 2014 or Berry, et al.
- •or a qualifying diagnosis per the Pediatric Spine Study Group definition of NMS.
- •All pediatric orthopaedic surgeons and neurosurgeons who treat neuromuscular scoliosis at our study sites will be eligible participants.
排除标准
- •Families whose child with NMS is less than 8 years of age at time of orthopaedic consultation because surgery at a younger age usually indicates an atypical case.
- •Children with the diagnosis of Becker's muscular dystrophy due to potential disease modifying therapies that may alter curve progression.
研究组 & 干预措施
Usual care
Participants receive usual care
Decision support tool
Participants receive the novel decision support tool
干预措施: Decision support tool (Behavioral)
结局指标
主要结局
Intention for NMS treatment
时间窗: Immediately after clinic visit
Parent degree of decision preference (1: no surgery-9: surgery)
次要结局
- Intention for not delaying treatment(Immediately after clinic visit)
- Acceptability of intervention(Immediately after clinic visit)
- Intention for NMS treatment(Immediately after clinic visit)
- Knowledge questions(Immediately after clinic visit)
- Decision conflict(Immediately after clinic visit)
- Worry(Immediately after clinic visit)
- Decisional self-efficacy(Immediately after clinic visit)
- Feasibility of intervention(Immediately after clinic visit)
- Physician trustworthiness(Immediately after clinic visit)
- Decision readiness(Immediately after clinic visit)
- Acceptability of Intervention- Qualitative(Within 3 months of clinic visit (for parents) and at end of study, approximately within 18 months of consent (for providers).)
- Quality of shared decision making(Immediately after clinic visit)
- Appropriateness of Intervention- Qualitative(Within 3 months of clinic visit (for parents) and at end of study, approximately within 18 months of consent (for providers).)
- Quality of shared decision making- qualitative(During clinic visit)
- Risk perception(Immediately after clinic visit)
- preference concordance for parents(Immediately after clinic visit)
- Preference concordance between parents and providers(Immediately after clinic visit)
- Appropriateness of intervention(Immediately after clinic visit)
- Feasibility of Intervention- Qualitative(Within 3 months of clinic visit (for parents) and at end of study, approximately within 18 months of consent (for providers).)